Wells Fargo & Company Amgen Inc Put Options Transaction History

Wells Fargo & Company

10 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 13, 2024	SELL	$262.75 - $319.31 $446,675 - $542,827	-1,700 Reduced 36.17%	3,000 $937,000
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $107,548 - $129,824	400 Added 9.3%	4,700 $1.34 Million
Q4 2023 Feb 09, 2024	SELL	$255.7 - $288.46 $1.18 Million - $1.33 Million	-4,600 Reduced 51.69%	4,300 $1.24 Million
Q3 2023 Nov 13, 2023	SELL	$218.65 - $271.46 $940,195 - $1.17 Million	-4,300 Reduced 32.58%	8,900 $2.39 Million
Q2 2023 Aug 15, 2023	SELL	$214.27 - $253.37 $1.11 Million - $1.32 Million	-5,200 Reduced 28.26%	13,200 $2.93 Million
Q1 2023 May 12, 2023	SELL	$225.79 - $275.2 $4.02 Million - $4.9 Million	-17,800 Reduced 49.17%	18,400 $4.45 Million
Q4 2022 Feb 13, 2023	SELL	$229.03 - $291.01 $6.12 Million - $7.77 Million	-26,700 Reduced 42.45%	36,200 $9.51 Million
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $5.84 Million - $6.58 Million	26,000 Added 70.46%	62,900 $14.2 Million
Q1 2022 May 16, 2022	BUY	$219.27 - $242.57 $8.09 Million - $8.95 Million	36,890 Added 368900.0%	36,900 $8.92 Million
Q1 2020 May 14, 2020	BUY	$182.24 - $241.7 $1,822 - $2,417	10 New	10 $17,000

3,055

409M

7.19M

6.26M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $171B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.